Effect of pegloticase on renal function in patients with chronic kidney disease: a post hoc subgroup analysis of 2 randomized, placebo-controlled, phase 3 clinical trials

por Yood, Robert A, Ottery, Faith D, Irish, William, Wolfson, Marsha
Publicado 2014

Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout

por Lipsky, Peter E, Calabrese, Leonard H, Kavanaugh, Arthur, Sundy, John S, Wright, David, Wolfson, Marsha, Becker, Michael A
Publicado 2014